Logo for the University of Illinois at Chicago
    • Login
    View Item 
    •   INDIGO Home
    • Pharmacy, College of
    • Pharmacy Practice, Department of
    • Publications - Pharmacy Practice
    • View Item
    •   INDIGO Home
    • Pharmacy, College of
    • Pharmacy Practice, Department of
    • Publications - Pharmacy Practice
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Sex differences in glutamate receptor gene expression in major depression and suicide

    Thumbnail
    View/Open
    Main article (1.356Mb)
    Date
    2015
    Author
    Gray, AL
    Hyde, TM
    Deep-Soboslay, A
    Kleinman, JE
    Sodhi, MS
    Publisher
    Nature Publishing Group
    Metadata
    Show full item record
    Abstract
    Accumulating data indicate that the glutamate system is disrupted in major depressive disorder (MDD), and recent clinical research suggests that ketamine, an antagonist of the N-methyl-D-aspartate (NMDA) glutamate receptor (GluR), has rapid antidepressant efficacy. Here we report findings from gene expression studies of a large cohort of postmortem subjects, including subjects with MDD and controls. Our data reveal higher expression levels of the majority of glutamatergic genes tested in the dorsolateral prefrontal cortex (DLPFC) in MDD (F21,59 = 2.32, P = 0.006). Posthoc data indicate that these gene expression differences occurred mostly in the female subjects. Higher expression levels of GRIN1, GRIN2A-D, GRIA2-4, GRIK1-2, GRM1, GRM4, GRM5 and GRM7 were detected in the female patients with MDD. In contrast, GRM5 expression was lower in male MDD patients relative to male controls. When MDD suicides were compared with MDD non-suicides, GRIN2B, GRIK3 and GRM2 were expressed at higher levels in the suicides. Higher expression levels were detected for several additional genes, but these were not statistically significant after correction for multiple comparisons. In summary, our analyses indicate a generalized disruption of the regulation of the GluRs in the DLPFC of females with MDD, with more specific GluR alterations in the suicides and in the male groups. These data reveal further evidence that, in addition to the NMDA receptor, the AMPA, kainate and the metabotropic GluRs may be targets for the development of rapidly acting antidepressant drugs.
    Type
    Article
    Date available in INDIGO
    2018-01-08T10:30:07Z
    URI
    http://hdl.handle.net/10027/19921
    Collections
    • Publications - Pharmacy Practice

    DSpace software copyright © 2002-2015  DuraSpace
    Contact Us | Send Feedback | Privacy Statement
    Theme by 
    Atmire NV

    Browse

    All of INDIGOCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    View Usage Statistics

    DSpace software copyright © 2002-2015  DuraSpace
    Contact Us | Send Feedback | Privacy Statement
    Theme by 
    Atmire NV